LRRK2 levels in immune cells are increased in Parkinson’s disease

QR Code

LRRK2 levels in immune cells are increased in Parkinson’s disease

Immune system regulation: A known suspect High levels of leucine-rich repeat kinase 2 (LRRK2) in immune cells disrupt immune system function in patients with Parkinson’s disease (PD). Mutations in LRRK2 are the most common genetic cause of PD. Although LRRK2 is found in many immune cells, research e...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	D. A. Cook, G. T. Kannarkat, A. F. Cintron, Laura M. Butkovich, Kyle B. Fraser, J. Chang, N. Grigoryan, S. A. Factor, Andrew B. West, J. M. Boss, M. G. Tansey
Format:	article
Langue:	EN
Publié:	Nature Portfolio 2017
Sujets:	Neurology. Diseases of the nervous system RC346-429
Accès en ligne:	https://doaj.org/article/6c926ddf8a1d4b89b93c4407e58bb695
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Is LRRK2 the missing link between inflammatory bowel disease and Parkinson’s disease?
par: Mary K. Herrick, et autres
Publié: (2021)

Loss of Parkinson’s susceptibility gene LRRK2 promotes carcinogen-induced lung tumorigenesis
par: Chandra Lebovitz, et autres
Publié: (2021)

Transcriptome analysis in LRRK2 and idiopathic Parkinson’s disease at different glucose levels
par: Rubén Fernández-Santiago, et autres
Publié: (2021)

Astrocytic atrophy as a pathological feature of Parkinson’s disease with LRRK2 mutation
par: Paula Ramos-Gonzalez, et autres
Publié: (2021)

LRRK2 inhibitors and their potential in the treatment of Parkinson’s disease: current perspectives
par: Atashrazm F, et autres
Publié: (2016)

LRRK2 kinase activity is dependent on LRRK2 GTP binding capacity but independent of LRRK2 GTP binding.
par: Jean-Marc Taymans, et autres
Publié: (2011)

LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson’s disease patients
par: Daniel Ysselstein, et autres
Publié: (2019)

Parkinson’s disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration
par: G. Carola, et autres
Publié: (2021)

A motif within the armadillo repeat of Parkinson’s-linked LRRK2 interacts with FADD to hijack the extrinsic death pathway
par: Nasia Antoniou, et autres
Publié: (2018)

The Gordon Research Seminar & Conference on Parkinson’s disease: state of the Science 200 years after James Parkinson’s essay on the Shaking Palsy
par: J. T. Greenamyre, et autres
Publié: (2017)

Cryo-EM analysis of homodimeric full-length LRRK2 and LRRK1 protein complexes
par: Kushal Sejwal, et autres
Publié: (2017)

A homologue of the Parkinson’s disease-associated protein LRRK2 undergoes a monomer-dimer transition during GTP turnover
par: Egon Deyaert, et autres
Publié: (2017)

Variable frequency of LRRK2 variants in the Latin American research consortium on the genetics of Parkinson’s disease (LARGE-PD), a case of ancestry
par: Mario Cornejo-Olivas, et autres
Publié: (2017)

Differences in MTHFR and LRRK2 variant’s association with sporadic Parkinson’s disease in Mexican Mestizos correlated to Native American ancestry
par: Elizabeth Romero-Gutiérrez, et autres
Publié: (2021)

Phosphorylation of 4E-BP1 in the mammalian brain is not altered by LRRK2 expression or pathogenic mutations.
par: Alzbeta Trancikova, et autres
Publié: (2012)

Understanding LRRK2 kinase activity in preclinical models and human subjects through quantitative analysis of LRRK2 and pT73 Rab10
par: Xiang Wang, et autres
Publié: (2021)

Inhibition of LRRK2 kinase activity promotes anterograde axonal transport and presynaptic targeting of α-synuclein
par: Charlotte F. Brzozowski, et autres
Publié: (2021)

Deletion of lrrk2 causes early developmental abnormalities and age-dependent increase of monoamine catabolism in the zebrafish brain.
par: Stefano Suzzi, et autres
Publié: (2021)

LRRK2 regulates retrograde synaptic compensation at the Drosophila neuromuscular junction
par: Jay Penney, et autres
Publié: (2016)

The IkappaB kinase family phosphorylates the Parkinson's disease kinase LRRK2 at Ser935 and Ser910 during Toll-like receptor signaling.
par: Nicolas Dzamko, et autres
Publié: (2012)

The gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis?
par: Madelyn C. Houser, et autres
Publié: (2017)

Mutación del gen LRRK2 se asocia a presentación autosómica dominante de la enfermedad de Parkinson en una familia chilena
par: Miranda C,Marcelo
Publié: (2007)

Cerebrospinal fluid biomarkers in Parkinson’s disease with freezing of gait: an exploratory analysis
par: J. M. Hatcher-Martin, et autres
Publié: (2021)

Fine-mapping, gene expression and splicing analysis of the disease associated LRRK2 locus.
par: Daniah Trabzuni, et autres
Publié: (2013)

Exploring human-genome gut-microbiome interaction in Parkinson’s disease
par: Zachary D. Wallen, et autres
Publié: (2021)

LRRK2 kinase regulates α-synuclein propagation via RAB35 phosphorylation
par: Eun-Jin Bae, et autres
Publié: (2018)

Ubiqutination via K27 and K29 chains signals aggregation and neuronal protection of LRRK2 by WSB1
par: Frederick C. Nucifora, et autres
Publié: (2016)

Aberrant Patterns of Sensory-Evoked Activity in the Olfactory Bulb of LRRK2 Knockout Mice
par: Andrea Maset, et autres
Publié: (2021)

Integrated molecular landscape of Parkinson’s disease
par: C. J. H. M. Klemann, et autres
Publié: (2017)

Abnormal center of mass feedback responses during balance: A potential biomarker of falls in Parkinson's disease.
par: J Lucas McKay, et autres
Publié: (2021)

INCREASING NOISE IMMUNITY OF CABLES FOR FIRE PROTECTION SYSTEMS
par: G. V. Bezprozvannych, et autres
Publié: (2020)

INCREASED SPONTANEOUS APOPTOSIS OF PERIPHERAL BLOOD LYMPHOCYTES FROM PATIENTS WITH PARKINSON’S DISEASE
par: S. N. Pchelina, et autres
Publié: (2014)

COMPLEMENT SYSTEM AS A MARKER OF IMMUNE DYSFUNCTION IN CHILDREN AUTISM SPECTRUM DISORDERS
par: E. G. Cheremnykh, et autres
Publié: (2019)

Parkinson’s disease managing reversible neurodegeneration
par: Hinz M, et autres
Publié: (2016)

Cooperative genome-wide analysis shows increased homozygosity in early onset Parkinson's disease.
par: Javier Simón-Sánchez, et autres
Publié: (2012)

Early constipation predicts faster dementia onset in Parkinson’s disease
par: M. Camacho, et autres
Publié: (2021)

Sex-based differences in the activation of peripheral blood monocytes in early Parkinson disease
par: Samantha M. Carlisle, et autres
Publié: (2021)

Parkinson's disease managing reversible neurodegeneration [Corrigendum]
par: Hinz M, et autres
Publié: (2016)

Parkinson’s Disease Managing Reversible Neurodegeneration [Retraction]
par: Hinz M, et autres
Publié: (2020)

Parkinson’s Disease Managing Reversible Neurodegeneration [Expression of Concern]
par: Hinz M, et autres
Publié: (2020)